About Malcolm Salter
Malcolm Salter filed with the SEC as director of C4 Therapeutics from 2020 to 2024.
Form D filings name Malcolm Salter as a director at AI Proteins.
Malcolm Salter reports to the SEC as a director of 1 public company.
Malcolm Salter first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Malcolm Salter in the role, so the role may have started earlier or lasted longer.
CI
C4 Therapeutics, Inc.
Director
2020 – 2024 · Public company (CCCC)
Key Colleagues at Startups
The people Malcolm Salter works with at each company, as listed on that company's latest Form D.
AI Proteins, Inc. · Form D, Apr 4, 2024
BS
Bobby Sandage
Director
JN
Julia Novina
Chief Legal Officer
CB
Chris Bahl
Executive officer and director
BE
Bruce Evans
Director
DD
Drew Dennison
Director
WD
Wendy Dwyer
Executive officer
TK
Todd Kaloudis
Director
NB
Noah Beerman
Executive officer and director